Cargando…
二甲双胍抗肺癌机制研究进展
Metformin, as a first-line drug in the treatment of type 2 diabetes, has been proved to be safe and effective. In recent years, epidemiological studies have found that metformin can inhibit the proliferation and metastasis of lung cancer cells, and is expected to become a new anti-lung cancer drug....
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210087/ https://www.ncbi.nlm.nih.gov/pubmed/32316716 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.02 |
Ejemplares similares
-
二甲双胍通过激活腺苷酸活化蛋白激酶(AMPK)的抗肿瘤机制
Publicado: (2013) -
紫檀芪抗肿瘤作用机制研究进展
Publicado: (2018) -
慢性移植物抗宿主病发病机制研究进展
Publicado: (2017) -
异硫氰酸酯抗肿瘤作用机制研究新进展
Publicado: (2017) -
抗肿瘤双特异性抗体研究进展与临床研发关注要点
Publicado: (2022)